Frédéric Morin

2k citations
11 papers · 1.6k · 1 hit paper · h-index 9

Impact in

Papers in

    • Osteoarthritis Treatment and Mechanisms 7
    • Spondyloarthritis Studies and Treatments 2
    • Musculoskeletal pain and rehabilitation 1

Frédéric Morin

11 papers receiving 1.4k citations

Frédéric Morin's Hit Papers

Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological disease-modifying anti-rheumatic drugs (COAST-V): 16 week results of a phase 3 randomised, double-blind, active-controlled and placebo-controlled trial 2018 · 290 citations
2900+2+5Years since publication50100150200250

Peers

Frédéric Morin
Comparison fields: 5 of 63
  • Rheumatology 692
  • Pathology and Forensic Medicine 343
  • Pharmacology 268
  • Anesthesiology and Pain Medicine 110
  • Surgery 424
Replace Ye‐Soo Park with:
Ye‐Soo Park South Korea
Oliver Grundnes Norway
Athanasios I. Georgountzos Greece
Erbil Oğuz Türkiye
Florent Eymard France
Ian Portek Australia
Heinrich Boehm Germany
Srihatach Ngarmukos Thailand
Charles Hutton United Kingdom
Manouk de Hooge Netherlands
Frédéric Morin relative to Ye‐Soo Park South Korea Ye‐Soo Park's profile →
Citations per field
00.5×2×4×6×7.7×
Ye‐Soo Park · 1×
Citations per year

Countries citing papers authored by Frédéric Morin

Since Specialization
Citations

This map shows the geographic impact of Frédéric Morin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frédéric Morin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frédéric Morin more than expected).

Fields of papers citing papers by Frédéric Morin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frédéric Morin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frédéric Morin. The network helps show where Frédéric Morin may publish in the future.

Co-authors

The 25 scholars most cited alongside Frédéric Morin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Frédéric Morin Line = papers co-authored together Frédéric Morin links everyone, so they are left out of the graph.

All Works

11 of 11 papers shown
#Work
1 1997463
2 2003340
3
Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological disease-modifying anti-rheumatic drugs (COAST-V): 16 week results of a phase 3 randomised, double-blind, active-controlled and placebo-controlled trial
Hit paper breakdown →
2018290
4 2019164
5 2011159
6 201643
7 202041
8 201035
9 201329
10 20163
11 20122

About Frédéric Morin

Frédéric Morin is a scholar working on Rheumatology, Pharmacology, Pathology and Forensic Medicine, Surgery and Nuclear Energy and Engineering, having authored 11 papers that have together received 1.6k indexed citations. Recurring topics across this work include Osteoarthritis Treatment and Mechanisms (7 papers), Spondyloarthritis Studies and Treatments (2 papers), Musculoskeletal pain and rehabilitation (1 paper), Shoulder Injury and Treatment (1 paper) and Spine and Intervertebral Disc Pathology (1 paper). The work is most often cited by research in Rheumatology (692 citations), Pathology and Forensic Medicine (343 citations), Pharmacology (268 citations), Anesthesiology and Pain Medicine (110 citations) and Surgery (424 citations). Frédéric Morin has collaborated with scholars based in Canada, United States and Czechia. Frequent co-authors include Caty Blanchette, Simon Carette, Louis Bessette, Sylvie Marcoux, Richard Leclaire, Gilbert A. Blaise, René Truchon, Jacques Lévesque, Jean-Pierre Pelletier and Jean‐Pierre Raynauld. Their work appears in journals such as The Lancet, Osteoarthritis and Cartilage, Annals of the Rheumatic Diseases, Cartilage and New England Journal of Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact